questionsmedicales.fr
Phénomènes génétiques
Phénotype
Sérogroupe
Sérogroupe : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Test ELISA
Immunofluorescence
Culture bactérienne
Identification des microorganismes
PCR
Détection des agents pathogènes
Historique médical
Évaluation clinique
Symptômes
5
Variabilité des symptômes
Sérogroupe
Complications
Gravité des symptômes
Évolution des symptômes
Traitement
Prévention
5
Prévention des infections
Hygiène
Efficacité des vaccins
Prévention
Hygiène
Prévention des infections
Voyages
Exposition aux infections
Comportements à risque
Prévention
Traitements
5
Traitement spécifique
Sérogroupe
Vaccins
Prévention des infections
Suivi médical
Efficacité du traitement
Médecine complémentaire
Traitements alternatifs
Complications
5
Septicémie
Complications infectieuses
Prévention des complications
Traitement précoce
Complications graves
Mortalité
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Immunodépression
Antécédents médicaux
Risque d'infection
Mode de vie
Prévention des infections
Voyages
Exposition aux infections
Conditions environnementales
Risque d'infection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sérogroupe : Questions médicales les plus fréquentes",
"headline": "Sérogroupe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sérogroupe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-30",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sérogroupe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénotype",
"url": "https://questionsmedicales.fr/mesh/D010641",
"about": {
"@type": "MedicalCondition",
"name": "Phénotype",
"code": {
"@type": "MedicalCode",
"code": "D010641",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.695"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sérogroupe",
"alternateName": "Serogroup",
"code": {
"@type": "MedicalCode",
"code": "D065288",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ray Borrow",
"url": "https://questionsmedicales.fr/author/Ray%20Borrow",
"affiliation": {
"@type": "Organization",
"name": "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom."
}
},
{
"@type": "Person",
"name": "Bo Pang",
"url": "https://questionsmedicales.fr/author/Bo%20Pang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn."
}
},
{
"@type": "Person",
"name": "Biao Kan",
"url": "https://questionsmedicales.fr/author/Biao%20Kan",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn."
}
},
{
"@type": "Person",
"name": "Lucy A McNamara",
"url": "https://questionsmedicales.fr/author/Lucy%20A%20McNamara",
"affiliation": {
"@type": "Organization",
"name": "Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tabletability and compactibility of",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37310086",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10837450.2023.2214614"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of tableting temperature on tablet properties and dissolution behavior of heat sensitive formulations.",
"datePublished": "2023-11-13",
"url": "https://questionsmedicales.fr/article/37967689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.123603"
}
},
{
"@type": "ScholarlyArticle",
"name": "Single-tablet-scale direct-compression: An on-demand manufacturing route for personalized tablets.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37507098",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.123274"
}
},
{
"@type": "ScholarlyArticle",
"name": "Enhancing tabletability of high-dose tablets by tailoring properties of spray-dried insulin particles.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36565770",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122526"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37312273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cpdd.1292"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénotype",
"item": "https://questionsmedicales.fr/mesh/D010641"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sérogroupe",
"item": "https://questionsmedicales.fr/mesh/D065288"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sérogroupe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sérogroupe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sérogroupe",
"description": "Comment identifier un sérogroupe spécifique ?\nQuels tests sont utilisés pour le diagnostic ?\nPeut-on diagnostiquer par culture ?\nLes tests PCR sont-ils utiles ?\nQuel rôle joue l'historique médical ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sérogroupe",
"description": "Quels symptômes sont associés aux infections par sérogroupe ?\nLes symptômes varient selon le sérogroupe ?\nY a-t-il des symptômes communs ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sérogroupe",
"description": "Comment prévenir les infections par sérogroupe ?\nLes vaccins sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes voyages augmentent-ils le risque ?\nLes comportements à risque à éviter ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sérogroupe",
"description": "Quels traitements sont disponibles pour les infections ?\nLes traitements varient-ils selon le sérogroupe ?\nLes vaccins sont-ils disponibles ?\nComment évaluer l'efficacité du traitement ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sérogroupe",
"description": "Quelles complications peuvent survenir ?\nLes complications varient-elles selon le sérogroupe ?\nComment prévenir les complications ?\nLes complications peuvent-elles être mortelles ?\nQuels signes indiquent des complications ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sérogroupe",
"description": "Quels sont les facteurs de risque d'infection ?\nLes antécédents médicaux influencent-ils le risque ?\nLe mode de vie joue-t-il un rôle ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes conditions environnementales influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Tablets#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un sérogroupe spécifique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des tests sérologiques qui détectent des anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et l'immunofluorescence sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par culture ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la culture de microorganismes peut aider à identifier le sérogroupe."
}
},
{
"@type": "Question",
"name": "Les tests PCR sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut détecter des séquences spécifiques de l'ADN des microorganismes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique aide à orienter les tests et à identifier les sérogroupes possibles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections par sérogroupe ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient, mais incluent fièvre, douleurs et inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le sérogroupe ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut provoquer des symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes communs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue et la fièvre sont souvent communs."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains sérogroupes peuvent entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver rapidement sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par sérogroupe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par la vaccination, l'hygiène et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins peuvent réduire significativement le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter les contacts avec des malades."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à risque peut augmenter l'exposition aux sérogroupes."
}
},
{
"@type": "Question",
"name": "Les comportements à risque à éviter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les foules et les contacts étroits avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ou antiviraux sont souvent utilisés selon le sérogroupe."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le sérogroupe ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut nécessiter un traitement spécifique."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains sérogroupes ont des vaccins pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par le suivi des symptômes et des tests sérologiques après traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements complémentaires peuvent être envisagés, mais doivent être validés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la septicémie ou des infections localisées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le sérogroupe ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque sérogroupe peut entraîner des complications spécifiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et approprié peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être graves et potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une aggravation des symptômes ou une nouvelle fièvre doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'immunodépression et les conditions de vie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections augmentent le risque de réinfection."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des sérogroupes spécifiques."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la pollution ou le surpeuplement peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
University of Manchester, Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Stopford Building, Manchester, United Kingdom.
3 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. pangbo@icdc.cn.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. kanbiao@icdc.cn.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Vaccine Medical Development, Scientific & Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Institut Pasteur, Invasive bacterial infections Unit and National Reference Centre for Meningococci and Haemophilus influenzae, Paris, France.
Publications dans "Sérogroupe" :
3 publications dans cette catégorie
Affiliations :
Institute for Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. Electronic address: vogel_u@ukw.de.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Animal Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Division of Microbiology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South Africa. lokisnyman@gmail.com.
Publications dans "Sérogroupe" :
2 publications dans cette catégorie
Affiliations :
Amsterdam UMC, University of Amsterdam, Netherlands Reference Laboratory for Bacterial Meningitis, The Netherlands.
Publications dans "Sérogroupe" :
This study aimed to evaluate a material sparing method to predict tabletability and compactibility relationships. Seven...
The tableting process involves the conversion of mechanical to thermal energy. This study evaluated the influence of temperature on the tableting behavior of formulations with different compositions. ...
Today's pharmaceutical industry is facing various challenges. Two of them are issues with supply chain security and the increasing demand for personalized medicine. Both can be addressed by increasing...
The oral delivery of proteins and peptides provides an attractive dosing option due to its high patient compliance. However, as oral formulations of such macromolecules require the addition of typical...
This single-center, randomized, open-label, single-dose, 2-group, 2-stage crossover trial evaluated the bioequivalence of 15 mg of mirogabalin as orally disintegrating tablets (ODTs) with conventional...
Mini-tablets are considered a promising solid dosage form in the pharmaceutical industry due to advantages such as dosing accuracy, efficiency as a drug delivery system, and alleged improvement in mec...
In this paper, the influence of powder properties and process parameters, such as punch shape and size, on the evolution of mechanical properties during the tableting process and the potential occurre...
The numerical simulation cases consist of four different die sizes, mini-tablets of 2 mm, and 3 mm, and conventionally sized tablets of 8 mm and 11.28 mm. Each tablet size is simulated using four dist...
The model predictions in terms of stress and density distribution at different stages of the compaction process indicate similar behavior in terms of density and stress distribution profiles between t...
Based on tablet size, small localized differences are noted (e.g., low-density regions, high shear bands, and heterogeneous density profiles), suggesting a possible risk of tableting defects for conve...
Predicting tablet defects, such as capping, that might occur during manufacturing, is a challenge in the pharmaceutical industry. In the literature, different parameters were presented to predict capp...
The plasticity of materials plays a critical role in adequate powder tabletability, which is required in developing a successful tablet product. Generally, a more plastic material can develop larger b...
Medication adherence can be challenging for persons with difficulty swallowing tablets. We investigated the bioequivalence of a dissolved tablet when compared with that of a whole tablet of the fixed-...
The effects of granule size of raw materials on tablet hardness (TH) and weight (TW) in the continuous tablet manufacturing process (CTMP) were investigated using near-infrared spectroscopy (NIRS)....
Granule materials of different sizes were prepared by extrusion granulation from a standard granule formula powder containing lactose/starch and 4.5% acetaminophen. Large-, small-, and medium-sized gr...
The best fitted calibration models for predicting TH and TW were obtained, with sufficient accuracy, based on NIRS using the partial least squares regression, and comprised both physical and chemical ...
The changes in the predicted value profiles of TH and TW using NIRS reflected the changes in the measured values depending on the raw granule size during CTMP....